|
|
180 Linden Avenue
Westbury, NY 11590 USA
phone:(516) 997-4600
fax:(516) 997-2299
|
|
| Symbol |
VASO.PK |
| Exchange |
OTC |
| Founded |
1986 |
| Employees |
109 |
|
|
| www.vasomedical.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Enhanced External Counterpulsation (EECP(R)) therapy systems for patients with heart disease; Ambulatory Monitoring and Patient Management products. |
|
| Management |
| Jun Ma, Ph.D, President and Chief Executive Officer, Director; John C.K. Hui, Ph.D, Chief Technology Officer, Chairman of Advisory Committee; Michael Beecher, CFO; Larry Liebman, Vice President, Sales and Marketing |
| |
|
|
|
|
|
|
|
| Keywords |
| cardiovascular, non-invasive, heart, coronary artery disease, Cardiology, cardiac, heart, coronary, counterpulsation, angina, congestive heart failure, chf, acute myocardial infarction, cardiogenic shock, chest pain, vasomedical |
|
|
|
| Description |
|
Vasomedical provides medical products and services that address clinical needs in the management of patients with heart disease. |
|
| Products / Services |
Vasomedical's EECP(R)therapy is a non-invasive and outpatient therapy for the treatment of diseases of the cardiovascular system indicated for use in cases of stable or unstable angina, congestive heart failure, acute myocardial infarction and cardiogenic shock. Vasomedical offers four unique EECP(R) therapy systems:
Lumenair(TM) EECP(R)Therapy System
AngioNew(R)-VI EECP(R) Therapy System
AngioNew(R)-V Mobile EECP(R) Therapy System
Model TS4 EECP(R) Therapy System
Holter Monitoring Products:
BIOX(TM) 2301/2302 2-in-1 Combo ECG & ABPM Holter
BIOX(TM) 1805 Ambulatory Blood Pressure Monitor
BIOX(TM) 1304/1305 ECG Holter Monitoring System
BIOX(TM) 1303 Ultra Compact 3-Channel ECG Holter
CB Series Analysis and Reporting Software
Patient Monitoring Products:
EZ ECG(TM) Monitor
EZ O2(TM) Adult Finger Pulse Oximeter
EZ O2(TM) Adult/Pediatric Finger Pulse Oximeter
EZ O2(TM) Wrist Pulse Oximeter
|
|
| Technology / Differentiation |
| EECP therapy extends the ability of interventional cardiologists and cardiothoracic surgeons to treat coronary artery disease, and provides non-interventional cardiologists with a means of treating patients who have become refractory to drugs. Data from Vasomedical's EECP(R) sponsored registries and studies and general clinical experience have shown that nearly 80% of treated patients achieve significant benefits from 35, 1-hour treatment sessions. |
|
| Market / Customers |
Interventional cardiologists and cardiothoracic surgeons use the company's technology to treat coronary artery disease.
The company markets its EECP(R) therapy systems through a direct sales force to hospitals, clinics, and physicians private practices in the United States; and distributes through a network of independent distributors internationally.
|
|
| Competitors / Substitutes / Alternatives |
Abiomed Inc., Medtronic Inc., St. Jude Medical Inc
|
|
| Strategy |
Broad-based clinical acceptance of EECP(TM) therapy.
|
|
| Status |
| With over 600 locations domestically, Vasomedical has approximately 80% market share and a leadership position with the Lumenair(TM) EECP(R) Therapy System. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members